- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03316846
Internet-delivered Cognitive Behavioral Therapy for Patients With Chronic Pain and Psychiatric Distress (TIPPS)
Tailored Internet-delivered Cognitive Behavioral Therapy for Patients With Chronic Pain and Comorbid Psychiatric Distress
This study is a randomized controlled trial studying the efficacy of an iCBT treatment for patients with chronic pain and comorbid psychiatric distress. Half the participants will receive treatment at first, while the other half serve as a control group. After the first group has received treatment, the same program will be offered to participants in the control group. Treatment will be tailored on the level of individual participants, enabling individuals suffering a wide range of problems to be recruited. The treatment will consist of a 10-week guided self-help program, followed by a booster program and follow-up one year later. During the curse of the treatment the participants will be guided via text communication by a licensed psychologist or a candidate psychologist on their last year of studies.
The primary hypothesis is that an individually tailored CBT-treatment administered through the internet can be beneficial for patients suffering from chronic pain and comorbid psychiatric distress. The investigators expect that patients in the treatment group will show reduced levels of disability, depression and anxiety, while improving on scales measuring coping and quality of life.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Patients suffering from chronic pain often experience comorbid psychiatric distress. Cognitive behavioral therapy (CBT) has been shown to be effective in treating both these problems. However delivering relevant treatment can be difficult due to logistics, cost and lack of personnel with required competence. Delivering CBT though the internet (iCBT) is a novel approach, sidestepping logistical issues while lowering costs. This however, is an area were research is lacking, and though there are several studies showing iCBT to be efficacious in treating both pain and psychiatric conditions, research on a combined approach is scarce.
This study will primarily investigate whether an individually tailored CBT-treatment administered through the internet can be beneficial for patients suffering from chronic pain and comorbid psychiatric conditions. The project will also clarify whether a following booster-program, also administered tough the internet, is helpful in maintaining and increasing effects of the initial treatment. Lastly, analysis of possible mediating variables will be able to give insight into the internal workings of the treatment itself, further elucidating efficacy of specific interventions, data which will be useful in future developments of treatment design.
The treatment will be based on a previously developed program, devised to target depression and anxiety in patients with chronic pain. The treatment will consist of a 10-week period where participants would get access to a series of treatment modules, each addressing a separate problem area using CBT techniques. The treatment includes modules addressing depression, anxiety, panic, worry, insomnia, stress, trauma, communication skills, and relaxation. The booster program will be based on the initial treatment, but will shorter, focusing on repetition, strategies for maintenance, and coping with setbacks. The platform used is an existing platform employed by Smärtcentrum at Uppsala university hospital for delivering internet based treatments.
The study will be conducted using a randomized controlled trial with a between-group design. Participants will be randomized to two groups, were one group will gain access to iCBT treatment while the second group will be a wait-list control, and will gain access to the program once treatment of the active group is finished. Participants will assessed by a licensed psychologist, and treatment modules assigned based on their individual needs. In addition to online CBT modules, consisting of information, exercises and homework assignments, all participants will have regular contact by secure email-channel with a licensed psychologist or last-year psychology student under supervision. This contact will guide treatment, providing support, feedback on homework, and if necessary clarify treatment content and help with IT-related problems interfering with treatment adherence. After a year, participants will be invited to take part in a follow-up module, consisting of limited treatment recapitulation and evaluation.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Uppland
-
Uppsala, Uppland, Sverige, 75236
- Department of Psychology, Uppsala University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Experienced pain for at least the three previous months
- Medically evaluated regarding the pain condition
- Experiences at least one type of psychological distress such as: depression, anxiety, insomnia or stress
- Access to, and ability to use, a personal computer with internet access
- Mastery of the swedish language
Exclusion Criteria:
- Currently undergoing or planning to undergo CBT-treatment during the course of the study
- Currently undergoing or planning to undergo major changes in pharmacotherapy during the course of the study, or have made such changes in the last 2 months
- Have planned surgical intervention during the course of the study
- Currently experiencing symptoms of severe depression (scores >16 on suicidality on M.I.N.I.)
- Currently experiencing significant symptoms of psychosis (fulfills M.I.N.I criteria for psychotic syndrome, current)
- Currently experiencing significant symptoms of alcohol or substance abuse (fulfills M.I.N.I criteria for alcohol- or substance use disorder)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Internet-delivered therapy
10 week, guided and individually tailored internet-delivered cognitive behavioral therapy.
|
|
|
Ingen inngripen: Wait list control group
Wait list control group, receives treatment at later point.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline in depressive symptoms
Tidsramme: at 10 weeks
|
Self reported change in depressive symptoms, Montgomery-Åsberg Depression Rating Scale (MADRS-S) Swedish version, 9 items
|
at 10 weeks
|
|
Change from baseline in depressive symptoms
Tidsramme: at one-year
|
Self reported change in depressive symptoms, Montgomery-Åsberg Depression Rating Scale (MADRS-S) Swedish version, 9 items
|
at one-year
|
|
Change from baseline in psychosocial consequences of pain
Tidsramme: at 10 weeks
|
Self reported psychosocial consequences of pain, West Haven-Yale Multidimensional Pain Inventory (WHY/MPI-S part 1), Swedish version, 22 items
|
at 10 weeks
|
|
Change from baseline in psychosocial consequences of pain
Tidsramme: at one-year
|
Self reported psychosocial consequences of pain, West Haven-Yale Multidimensional Pain Inventory (WHY/MPI-S part 1), Swedish version, 22 items
|
at one-year
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline in anxiety sensitivity
Tidsramme: at 10 weeks
|
Self reported anxiety sensitivity, Anxiety Sensitivity Index (ASI), Swedish version, 16 items
|
at 10 weeks
|
|
Change from baseline in anxiety sensitivity
Tidsramme: at one-year
|
Self reported anxiety sensitivity, Anxiety Sensitivity Index (ASI), Swedish version, 16 items
|
at one-year
|
|
Change from baseline in symptoms of depression and anxiety
Tidsramme: at 10 weeks
|
Self reported symptoms of depression and anxiety, Hospital Anxiety and Depression Scale (HADS), Swedish version, 14 items
|
at 10 weeks
|
|
Change from baseline in symptoms of depression and anxiety
Tidsramme: at one-year
|
Self reported symptoms of depression and anxiety, Hospital Anxiety and Depression Scale (HADS), Swedish version, 14 items
|
at one-year
|
|
Change from baseline in pain disability
Tidsramme: at 10 weeks
|
Self reported pain disability, Pain Disability Index (PDI), Swedish version, 7 items
|
at 10 weeks
|
|
Change from baseline in pain disability
Tidsramme: at one-year
|
Self reported pain disability, Pain Disability Index (PDI), Swedish version, 7 items
|
at one-year
|
|
Change from baseline in quality of life
Tidsramme: at 10 weeks
|
Self reported quality of life, Quality of Life Inventory (QOLI), Swedish version, 7 items
|
at 10 weeks
|
|
Change from baseline in quality of life
Tidsramme: at one-year
|
Self reported quality of life, Quality of Life Inventory (QOLI), Swedish version, 7 items
|
at one-year
|
|
Fear of pain due to movement
Tidsramme: Baseline only
|
Self reported fear of movement, Tampa Scale of Kinesiophobia (TSK), Swedish version, 17 items
|
Baseline only
|
|
Change from baseline in insomnia symptoms
Tidsramme: at 10 weeks
|
Self reported insomnia symptoms, Insomnia Severity Index (ISI), Swedish version
|
at 10 weeks
|
|
Change from baseline in insomnia symptoms
Tidsramme: at one-year
|
Self reported insomnia symptoms, Insomnia Severity Index (ISI), Swedish version
|
at one-year
|
|
Change from baseline in PTSD symptoms
Tidsramme: at 10 weeks
|
Self reported PTSD symptoms, Post-Traumatic Stress Disorder checklist 5 (PCL-5), Swedish version
|
at 10 weeks
|
|
Change from baseline in PTSD symptoms
Tidsramme: at one-year
|
Self reported PTSD symptoms, Post-Traumatic Stress Disorder checklist 5 (PCL-5), Swedish version
|
at one-year
|
|
Change from baseline in stress
Tidsramme: at 10 weeks
|
Self reported stress, Shirom-Melomed Burnout Questionnaire (SMBQ), Swedish version
|
at 10 weeks
|
|
Change from baseline in stress
Tidsramme: at one-year
|
Self reported stress, Shirom-Melomed Burnout Questionnaire (SMBQ), Swedish version
|
at one-year
|
|
Change from baseline in GAD-symptoms
Tidsramme: at 10 weeks
|
Self reported GAD-symptoms , Generalized Anxiety Disorder 7 (GAD-7), Swedish version
|
at 10 weeks
|
|
Change from baseline in GAD-symptoms
Tidsramme: at one-year
|
Self reported GAD-symptoms , Generalized Anxiety Disorder 7 (GAD-7), Swedish version
|
at one-year
|
|
Change from baseline in pain catastrophizing
Tidsramme: at 5 weeks
|
Self reported pain catastrophizing, Pain Catastrophizing Scale (PCS), Swedish version
|
at 5 weeks
|
|
Change from baseline in pain catastrophizing
Tidsramme: at 10 weeks
|
Self reported pain catastrophizing, Pain Catastrophizing Scale (PCS), Swedish version
|
at 10 weeks
|
|
Change from baseline in pain catastrophizing
Tidsramme: at one-year
|
Self reported pain catastrophizing, Pain Catastrophizing Scale (PCS), Swedish version
|
at one-year
|
|
Change from baseline in coping strategies
Tidsramme: at one-year
|
Self reported coping strategies , Coping Strategies Questionnaire - Revised (CSQ-R), Swedish version
|
at one-year
|
|
Change from baseline in coping strategies
Tidsramme: at 5 weeks
|
Self reported coping strategies , Coping Strategies Questionnaire - Revised (CSQ-R), Swedish version
|
at 5 weeks
|
|
Change from baseline in coping strategies
Tidsramme: at 10 weeks
|
Self reported coping strategies , Coping Strategies Questionnaire - Revised (CSQ-R), Swedish version
|
at 10 weeks
|
|
Change from baseline in pain acceptance
Tidsramme: at 5 weeks
|
Self reported pain acceptance, Chronic Pain Acceptance Questionnaire (CPAQ), Swedish version
|
at 5 weeks
|
|
Change from baseline in pain acceptance
Tidsramme: at 10 weeks
|
Self reported pain acceptance, Chronic Pain Acceptance Questionnaire (CPAQ), Swedish version
|
at 10 weeks
|
|
Change from baseline in pain acceptance
Tidsramme: at one-year
|
Self reported pain acceptance, Chronic Pain Acceptance Questionnaire (CPAQ), Swedish version
|
at one-year
|
|
Change from baseline in self efficacy
Tidsramme: at 5 weeks
|
Self reported pain related self efficacy, Pain Self Efficacy-2 (PSEQ-2), Swedish version
|
at 5 weeks
|
|
Change from baseline in self efficacy
Tidsramme: at 10 weeks
|
Self reported pain related self efficacy, Pain Self Efficacy-2 (PSEQ-2), Swedish version
|
at 10 weeks
|
|
Change from baseline in self efficacy
Tidsramme: at one-year
|
Self reported pain related self efficacy, Pain Self Efficacy-2 (PSEQ-2), Swedish version
|
at one-year
|
|
Treatment credibility rating
Tidsramme: Baseline only
|
Self reported treatment credibility, Treatment Credibility Scale (TCS), Swedish version
|
Baseline only
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Studiestol: Gerhard Andersson, Professor, Linkoeping University
- Studiestol: Torsten Gordh, Professor, Uppsala University
- Studieleder: Monica Buhrman, PhD, Uppsala University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 140371
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Kronisk smerte
-
Southern College of OptometryRekrutteringØyesykdommer | Tørre øyne | Eyes Dry ChronicForente stater
-
University of MiamiHar ikke rekruttert ennåØyesykdommer | Tørre øyne | Eyes Dry ChronicForente stater
-
Clínica de Oftalmología de Cali S.AFullførtMeibomian kjerteldysfunksjon | Eyes Dry ChronicColombia
-
Istanbul University - CerrahpasaRekrutteringPatellofemoral Pain, PFPTyrkia (Türkiye)
-
Beijing Sport UniversityHar ikke rekruttert ennåPatellofemoral Pain, PFP
-
Beijing Sport UniversityHar ikke rekruttert ennå
-
Future University in EgyptFullført
-
Camilo Jose Cela UniversityFullførtMyofascial Pain Syndrome (MPS)Spania
-
Pamukkale UniversityHar ikke rekruttert ennåPatellofemoral Pain, PFPTyrkia (Türkiye)
-
Beijing Sport UniversityFullførtPatellofemoral Pain, PFPKina
Kliniske studier på Internet-Delivered Cognitive Behavioral Therapy
-
Medical University of South CarolinaNational Institute of Mental Health (NIMH)FullførtDepresjon | Depressive symptomerForente stater
-
Medical University of South CarolinaFullførtDepresjon | Kreft | Depressive symptomerForente stater
-
Medical University of South CarolinaNational Cancer Institute (NCI)RekrutteringDepresjon | Kreft | Depressive symptomerForente stater
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health...FullførtDepresjon | Depressive symptomer | UngdomsadferdForente stater
-
Nemours Children's ClinicFullførtDiabetes mellitus, type 2 | BarnefedmeForente stater
-
Nemours Children's ClinicFullførtDiabetes mellitus, type 2 | BarnefedmeForente stater
-
Medical University of South CarolinaDrug Abuse Research Training ProgramFullført
-
National Institute on Alcohol Abuse and Alcoholism...FullførtAlkoholdrikking | Alkoholisme | Alkoholmisbruk | Alkoholrelaterte lidelserForente stater
-
M.D. Anderson Cancer CenterRekrutteringDepresjon | Kreft | Utmattelse | Sove | AngstForente stater
-
University of GreifswaldGerman Research Foundation; Charite University, Berlin, Germany; Hannover... og andre samarbeidspartnereRekrutteringBehandlingsresistent depresjon | Vedvarende depressiv lidelseTyskland